5

onkologi-21-fin-apr-2017 · Kuva 3 177Lu-PSMA-617 at 24 hr 2nd 177Lu-PSMA-617 at 24 hr 177 Esimerkki Lu-PSMA-617-hoitoannoskuvauksesta gammakameralla. Tällä potilaalla on verraten

Download PDF Report

Upload
others
View
8
Download
0

Embed Size (px)

Citation preview

Page 1: onkologi-21-fin-apr-2017 · Kuva 3 177Lu-PSMA-617 at 24 hr 2nd 177Lu-PSMA-617 at 24 hr 177 Esimerkki Lu-PSMA-617-hoitoannoskuvauksesta gammakameralla. Tällä potilaalla on verraten

Page 2: onkologi-21-fin-apr-2017 · Kuva 3 177Lu-PSMA-617 at 24 hr 2nd 177Lu-PSMA-617 at 24 hr 177 Esimerkki Lu-PSMA-617-hoitoannoskuvauksesta gammakameralla. Tällä potilaalla on verraten

Page 3: onkologi-21-fin-apr-2017 · Kuva 3 177Lu-PSMA-617 at 24 hr 2nd 177Lu-PSMA-617 at 24 hr 177 Esimerkki Lu-PSMA-617-hoitoannoskuvauksesta gammakameralla. Tällä potilaalla on verraten

Page 4: onkologi-21-fin-apr-2017 · Kuva 3 177Lu-PSMA-617 at 24 hr 2nd 177Lu-PSMA-617 at 24 hr 177 Esimerkki Lu-PSMA-617-hoitoannoskuvauksesta gammakameralla. Tällä potilaalla on verraten

Page 5: onkologi-21-fin-apr-2017 · Kuva 3 177Lu-PSMA-617 at 24 hr 2nd 177Lu-PSMA-617 at 24 hr 177 Esimerkki Lu-PSMA-617-hoitoannoskuvauksesta gammakameralla. Tällä potilaalla on verraten

177Lu-DOTA-octreotate Radionuclide Therapy of ...562732/FULLTEXT01.pdfGarske-Román, U. 2012. 177Lu-DOTA-octreotate Radionuclide Therapy of Neuroendocrine Tumours: Dosimetry-Based

177Lu-DOTA-octreotate Radionuclide Therapy of ...562732/FULLTEXT01.pdfGarske-Román, U. 2012. 177Lu-DOTA-octreotate Radionuclide Therapy of Neuroendocrine Tumours: Dosimetry-Based

Documents

177Lu-labelled macrocyclic bisphosphonates for targeting

177Lu-labelled macrocyclic bisphosphonates for targeting

Documents

Dosimetry of 177Lu-PSMA-617 in Metastatic Castration ...jnm.snmjournals.org/content/60/4/517.full.pdf · Dosimetry of 177Lu-PSMA-617 in Metastatic Castration- Resistant Prostate Cancer:

Dosimetry of 177Lu-PSMA-617 in Metastatic Castration ...jnm.snmjournals.org/content/60/4/517.full.pdf · Dosimetry of 177Lu-PSMA-617 in Metastatic Castration- Resistant Prostate Cancer:

Documents

ATACs fighting Cancer...2019/11/25 · PSMA -ATAC – Prostate Cancer – Next Potential ATAC Development Candidate • PSMA is a clinically validated target, e.g. 177Lu -PSMA -617,

ATACs fighting Cancer...2019/11/25 · PSMA -ATAC – Prostate Cancer – Next Potential ATAC Development Candidate • PSMA is a clinically validated target, e.g. 177Lu -PSMA -617,

Documents

Psb-psma Ikhlas berbagi rela memberi. psb-psma Rela berbagi ikhlas memberi

Psb-psma Ikhlas berbagi rela memberi. psb-psma Rela berbagi ikhlas memberi

Documents

Social networking for lawyers psma

Social networking for lawyers psma

Education

· Web viewAnalysis of PSMA Expression and Outcome in Patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand Therapy . Robert Seifert1,2,3,4, Konstantin Seitzer1,4,5,

· Web viewAnalysis of PSMA Expression and Outcome in Patients with advanced Prostate Cancer receiving 177Lu-PSMA-617 Radioligand Therapy . Robert Seifert1,2,3,4, Konstantin Seitzer1,4,5,

Documents

Peptide Receptor Radionuclide Therapy using 177Lu octreotate

Peptide Receptor Radionuclide Therapy using 177Lu octreotate

Documents

177Lu-PSMA targeted Radionuclide Therapy€¦ · Gaertner et al. Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer. Oncotarget,

177Lu-PSMA targeted Radionuclide Therapy€¦ · Gaertner et al. Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer. Oncotarget,

Documents

PSMA - Power Sources Manufacturers Association

PSMA - Power Sources Manufacturers Association

Documents

Production and chemical processing of 177Lu for nuclear ... · nuclear decay characteristics. Radiopharmaceuticals containing 177Lu are currently under development and tested for

Production and chemical processing of 177Lu for nuclear ... · nuclear decay characteristics. Radiopharmaceuticals containing 177Lu are currently under development and tested for

Documents

68Ga- and 177Lu-labeled PSMA I&T: Optimization of a PSMA ...jnm.snmjournals.org/content/early/2015/06/17/jnumed.115.158550.full.pdf · 1 Pharmaceutical Radiochemistry, Technische

68Ga- and 177Lu-labeled PSMA I&T: Optimization of a PSMA ...jnm.snmjournals.org/content/early/2015/06/17/jnumed.115.158550.full.pdf · 1 Pharmaceutical Radiochemistry, Technische

Documents

Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide

Guidance on 177Lu-DOTATATE Peptide Receptor Radionuclide

Documents

Transcriptional effects of 177Lu-octreotate therapy using ... · ORIGINAL RESEARCH Open Access Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule

Transcriptional effects of 177Lu-octreotate therapy using ... · ORIGINAL RESEARCH Open Access Transcriptional effects of 177Lu-octreotate therapy using a priming treatment schedule

Documents

Homenagem PSMA - Padre Bonfim

Homenagem PSMA - Padre Bonfim

Documents

Research Paper 177Lu-Labeled Phosphoramidate-Based … · Research Paper 177Lu-Labeled ... as inhibitors of PSMA’s enzymatic activity, ... 6-8 weeks) were purchased from Charles

Research Paper 177Lu-Labeled Phosphoramidate-Based … · Research Paper 177Lu-Labeled ... as inhibitors of PSMA’s enzymatic activity, ... 6-8 weeks) were purchased from Charles

Documents

Betalutin (177Lu-Lilotomab) - Studio ER Congressi ... · Betalutin (177Lu-Lilotomab) Arne Kolstad Oslo University Hospital Norway May 10, 2016 . ... • Firenze - Prof. Bosi •Poland

Betalutin (177Lu-Lilotomab) - Studio ER Congressi ... · Betalutin (177Lu-Lilotomab) Arne Kolstad Oslo University Hospital Norway May 10, 2016 . ... • Firenze - Prof. Bosi •Poland

Documents

Evaluation of safety and dosimetry of 177Lu-DOTA-ZOL for ...2021/01/08 · Ga-PSMA-11 (n=2) or 18 F-PSMA-66 1007 (n=7) PET/CT scans within one week prior to therapy. Blood biomarkers

Evaluation of safety and dosimetry of 177Lu-DOTA-ZOL for ...2021/01/08 · Ga-PSMA-11 (n=2) or 18 F-PSMA-66 1007 (n=7) PET/CT scans within one week prior to therapy. Blood biomarkers

Documents

The Intratumoral Distribution of Radiolabeled 177Lu … · Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies ... The Intratumoral Distribution of Radiolabeled

The Intratumoral Distribution of Radiolabeled 177Lu … · Intratumoral Distribution of Radiolabeled 177Lu-BR96 Monoclonal Antibodies ... The Intratumoral Distribution of Radiolabeled

Documents

PSMA Ligands for Radionuclide Imaging and Therapy of ... · agnostic imaging and therapy in patients with PCa with radiolabeled PSMA ligands is provided. Key words: PSMA, prostate

PSMA Ligands for Radionuclide Imaging and Therapy of ... · agnostic imaging and therapy in patients with PCa with radiolabeled PSMA ligands is provided. Key words: PSMA, prostate

Documents

Production of 177Lu at the IFMIF-DONES Facility

Production of 177Lu at the IFMIF-DONES Facility

Documents

Padronizacao Absoluta Do 177lu e Do 111in

Padronizacao Absoluta Do 177lu e Do 111in

Documents

177Lu – DOTA0 – Tyr3] – OCTREOTATE PARA EL TRATAMIENTO …

177Lu – DOTA0 – Tyr3] – OCTREOTATE PARA EL TRATAMIENTO …

Documents

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of … · 2020-02-06 · PSA serum levels. 68Ga-PSMA-11 PET/CT revealed a higher ... Preparation of radio-labeled PSMA-targeting

The 68Ga/177Lu-theragnostic concept in PSMA-targeting of … · 2020-02-06 · PSA serum levels. 68Ga-PSMA-11 PET/CT revealed a higher ... Preparation of radio-labeled PSMA-targeting

Documents

PRODUCTION AND QUALITY CONTROL OF 177Lu-DOTATATE …

PRODUCTION AND QUALITY CONTROL OF 177Lu-DOTATATE …

Documents

Health & Medicine

Presentacion oct2015 psma

Presentacion oct2015 psma

Documents

Directorio psma 2015

Directorio psma 2015

Documents

Production and chemical processing of 177Lu for - mediaTUM

Production and chemical processing of 177Lu for - mediaTUM

Documents

Recherche zu Prostata-Karzinom: PSMA-PET · Recherche PSMA 19.05.2016 © 2016 1 Recherche zu Prostata-Karzinom: PSMA-PET 1 PICO-Frage .....2

Recherche zu Prostata-Karzinom: PSMA-PET · Recherche PSMA 19.05.2016 © 2016 1 Recherche zu Prostata-Karzinom: PSMA-PET 1 PICO-Frage .....2

Documents